Order Article Reprints

Naguib S, DeJulius CR, Backstrom JR, Haider AA, Ang JM, Boal AM, Calkins DJ, Duvall CL, Rex TS. Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway. Antioxidants. 2023; 12(3):556. https://doi.org/10.3390/antiox12030556

Naguib, Sarah, Carlisle R. DeJulius, Jon R. Backstrom, Ameer A. Haider, John M. Ang, Andrew M. Boal, David J. Calkins, Craig L. Duvall, and Tonia S. Rex. 2023. "Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway" Antioxidants 12, no. 3: 556. https://doi.org/10.3390/antiox12030556

Naguib, S., DeJulius, C. R., Backstrom, J. R., Haider, A. A., Ang, J. M., Boal, A. M., Calkins, D. J., Duvall, C. L., & Rex, T. S. (2023). Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway. Antioxidants, 12(3), 556. https://doi.org/10.3390/antiox12030556